The company said it would use the funding to tackle the gaps in clinical practices that need addressing in the Northern Ireland and UK region.
Founded in 2005, Diaceutics focuses on delivering diagnostic testing strategies to its clients through collating large amounts of data. The company has recently announced its continued growth and performance this year having achieved a 24% revenue growth.
Ryan Keeling, chief executive of Diaceutics, said: "We are very grateful to the UKRI for awarding this funding, which we will deploy to support our R&D activities.
"Initiatives such as this are very important and will help us progress our data products, clinical data & bioinformatics pipeline development, staff skills and apprenticeships development."
